CIBC Private Wealth Group
ONCY

CIBC Private Wealth Group’s Oncolytics Biotech ONCY Stock Holding History

CIBC Private Wealth Group’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$43.7K Buy
+50,000
New +$54K ﹤0.01% 1842

Other funds holding ONCY

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
SI
Seeds Investor New York $735M AUM 17.54% 1-Year Est. Return
IAIM
International Assets Investment Management Orlando, Florida $1.67B AUM 28.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $121M AUM 39.82% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return

CIBC Private Wealth Group's ONCY Position: Q4 2025 in Review

CIBC Private Wealth Group opened a new position in Oncolytics Biotech (ONCY) in Q4 2025: 50,000 shares worth $43.7K. The stake represents ﹤0.01% of the portfolio and ranks #1842 among its holdings.

61 funds tracked by Wall St. Rank hold ONCY as of Q4 2025.

  • CIBC Private Wealth Group held 50,000 shares of Oncolytics Biotech worth $43.7K as of Q4 2025.
  • Oncolytics Biotech was a new CIBC Private Wealth Group position in Q4 2025.
  • Oncolytics Biotech made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #1842 holding.
  • 61 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.